共 158 条
[1]
Joensuu H(2002)Management of malignant gastrointestinal stromal tumours Lancet Oncol. 3 655-664
[2]
Fletcher C(2017)Gastroenterological surgery in Japan: the past, the present and the future Ann Gastroenterol Surg. 1 5-10
[3]
Dimitrijevic S(1998)Gain-offunction mutations of c-kit in human gastrointestinal stromal tumors Science 279 577-580
[4]
Silberman S(1998)Familial gastrointestinal stromal tumours with germline mutation of the kit gene Nat Genet 19 323-324
[5]
Roberts P(2004)Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs) Oncogene 23 3999-4006
[6]
Demetri G(2008)Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 J Clin Oncol 26 626-632
[7]
Colvin H(2005)Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants Gastroenterology 128 270-279
[8]
Mizushima T(2008)The many faces of the SOCS box Cytokine Growth Factor Rev 19 371-381
[9]
Eguchi H(1997)Structure and function of a new STAT-induced STAT inhibitor Nature 387 924-929
[10]
Takiguchi S(2012)Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells Int J Cancer 131 1287-1296